Lung cancer and leukaemia treatments to be added to PBS

19 November 2019 - “Game changing” drugs for types of lung cancer and leukaemia will be added to the Pharmaceutical Benefits ...

Read more →

Rare Disease Fund now covers Pompe disease, a rare inherited neuromuscular disorder

3 November 2019 - The Rare Disease Fund now covers Singaporeans with Pompe disease - a rare inherited neuromuscular disorder ...

Read more →

It’s tiny biotechs — not big drug makers — that fear ‘nuclear winter’ from Pelosi’s drug pricing bill

12 November 2019 - No one asked Paul Hastings what he thinks about Speaker Nancy Pelosi’s major new drug pricing ...

Read more →

Google’s ‘Project Nightingale’ gathers personal health data on millions of Americans

11 November 2019 - Search giant is amassing health records from Ascension facilities in 21 states; patients not yet informed. ...

Read more →

Merck’s Ervebo [Ebola Zaire vaccine (rVSVΔG-ZEBOV-GP) live] granted conditional approval in the European Union

12 November 2019 - Authorisation represents significant advancement in the global response to Ebola. ...

Read more →

Lung cancer ALK+NSCLC genetic mutation screening could save lives - doctors

12 November 2019 - Lives are being needlessly cut short because there's no universal testing for a type of lung ...

Read more →

Three deaths following epilepsy drug brand switch

12 November 2019 - Three deaths have been reported to the Centre for Adverse Reactions Monitoring after PHARMAC forced patients ...

Read more →

Breast and kidney cancer drugs get approval for use across Scotland's NHS

11 November 2019 - Medicines for breast and kidney cancers are among five new drugs which can now be used ...

Read more →

FDA admits it goofed when granting orphan status to an opioid addiction treatment

8 November 2019 - In an unusual move, the FDA has acknowledged a mistake and revoked orphan drug status for ...

Read more →

U.S. FDA accepts for priority review Bristol-Myers Squibb’s application for Opdivo (nivolumab) plus Yervoy (ipilimumab) combination for patients with previously treated advanced hepatocellular carcinoma

11 November 2019 - The FDA also granted Opdivo plus Yervoy Breakthrough Therapy Designation for this potential indication. ...

Read more →

F2G receives US FDA breakthrough therapy designation for Olorofim

11 November 2019 - First anti-fungal agent to receive breakthrough therapy designation. ...

Read more →

Lipocine receives complete response letter for Tlando from U.S. FDA

11 November 2019 - Lipocine announced today that it has received a complete response letter from the United States Food ...

Read more →

Medical cannabis ruled out for chronic pain by NHS drug watchdog in decision branded 'devastating'

11 November 2019 - Cannabis should not be prescribed for chronic pain, the NHS funding watchdog has ruled, in a ...

Read more →

More than ever, Democratic presidential hopefuls want to take on pharma. Here’s how they’d do it.

11 November 2019 - President Trump has made drug pricing a key policy tenet of his three-year tenure in the ...

Read more →

China’s drug market is opening up

11 November 2019 - Beijing’s health-care reforms are giving global pharmaceutical companies better access to the world’s second-largest drug market. ...

Read more →

SMC - November 2019 decisions

11 November 2019 - A medicine used to treat advanced breast cancer has today been accepted by the SMC for ...

Read more →